UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Patient perspective of tardive dyskinesia: results from a social media listening study

BMC psychiatry, 2021-02, Vol.21 (1), p.94-8, Article 94

2021

Volltextzugriff (PDF)

Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study

Frontiers in endocrinology (Lausanne), 2022-11, Vol.13, p.1005963-1005963

2022

Volltextzugriff (PDF)

Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study

Journal of patient-reported outcomes, 2023-03, Vol.7 (1), p.21-21, Article 21

2023

Volltextzugriff (PDF)

Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review

The mental health clinician, 2023-10, Vol.13 (5), p.225-232

2023

Volltextzugriff (PDF)

118 Demographics and Real World Healthcare Cost and Utilization for Patients With Probable Tardive Dyskinesia

CNS spectrums, 2018-02, Vol.23 (1), p.75-75

2018

Volltextzugriff (PDF)

Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia

Journal of comparative effectiveness research, 2019-10, Vol.8 (13), p.1077-1088

2019

Volltextzugriff (PDF)

TeleSCOPE: A Real-World Study of Telehealth for the Detection and Treatment of Drug-Induced Movement Disorders

CNS spectrums, 2022-04, Vol.27 (2), p.250-250

2022

Volltextzugriff (PDF)

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings

Journal of clinical psychopharmacology, 2020-05, Vol.40 (3), p.259

2020

Volltextzugriff (PDF)

Concerns from Community Mental Health Center (CMHC) Patients Regarding Drug-Induced Movement Disorders: Impact on Functioning and Treatment Beliefs

CNS spectrums, 2021-04, Vol.26 (2), p.152-152

2021

Volltextzugriff (PDF)

Clinician-Reported Patient Awareness of Symptoms and Severity of Tardive Dyskinesia in Patients Prescribed VMAT2 Inhibitors

CNS spectrums, 2021-04, Vol.26 (2), p.151-151

2021

Volltextzugriff (PDF)

The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder

Journal of affective disorders, 2019-03, Vol.246, p.217-223

2019

Volltextzugriff (PDF)

Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey

Seizure (London, England), 2022-04, Vol.97, p.50-57

2022

Volltextzugriff (PDF)

Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study

Journal of the American Psychiatric Nurses Association, 2023-09, Vol.29 (5), p.389-399

2023

Volltextzugriff (PDF)

Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson's disease patients treated with levodopa/carbidopa

Journal of medical economics, 2021-01, Vol.24 (1), p.563-569

2021

Volltextzugriff (PDF)

Article Selected to Receive the Mitchell B. Balter Award for 2021

Journal of clinical psychopharmacology, 2021-07, Vol.41 (4), p.362

Kern, Barbara

2021

Volltextzugriff (PDF)

RE-KINECT, A REAL-WORLD, PROSPECTIVE TARDIVE DYSKINESIA SCREENING STUDY: AN EVALUATION OF BASELINE CHARACTERISTICS IN OLDER PATIENTS

The American journal of geriatric psychiatry, 2019-03, Vol.27 (3), p.S217-S219

2019

Volltextzugriff (PDF)

PSAT095 Examination of Treatment Patterns in Patients with Classic Congenital Adrenal Hyperplasia (CAH) Compared to Treatment Guidelines

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A117-A117

2022

Volltextzugriff (PDF)

105 Health-Related Quality of Life in Patients with Possible Tardive Dyskinesia Based on Patient and Clinician Assessments

CNS spectrums, 2020-04, Vol.25 (2), p.268-269

2020

Volltextzugriff (PDF)

117 RE-KINECT: Real-World Dyskinesia Screening Study and Registry in Patients Taking Antipsychotic Agents: Interim Baseline Burden of Illness Results

CNS spectrums, 2018-02, Vol.23 (1), p.74-74

2018

Volltextzugriff (PDF)

PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia

Journal of the Endocrine Society, 2022-11, Vol.6 (Supplement_1), p.A118-A118

2022

Volltextzugriff (PDF)

6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECT Study

CNS spectrums, 2019-02, Vol.24 (1), p.176-177

2019

Volltextzugriff (PDF)

38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia

CNS spectrums, 2019-02, Vol.24 (1), p.195-196

2019

Volltextzugriff (PDF)

MON-183 Adrenal Androgen Control and Steroidal Side Effects in Adolescents and Adults with Congenital Adrenal Hyperplasia Treated with Glucocorticoids

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECTStudy

CNS spectrums, 2019-02, Vol.24 (1), p.176

2019

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Antipsychotics
(9)
Dyskinesia
(9)
Humans
(8)
Psychotropic Drugs
(8)
Tardive Dyskinesia
(8)
Psychiatry
(6)
Abstracts
(5)
Movement Disorders
(5)
Patients
(5)
Quality Of Life
(5)
Adrenal
(3)
Antipsychotic Agents - Adverse Effects
(3)
Health Care Sciences & Services
(3)
Schizophrenia
(3)
Tardive Dyskinesia - Chemically Induced
(3)
Valbenazine
(3)
Antipsychotic Agents
(2)
Care And Treatment
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient perspective of tardive dyskinesia: results from a social media listening study

Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study

Impact of possible tardive dyskinesia on physical wellness and social functioning: results from the real-world RE-KINECT study

Exploring real-world symptom impact and improvement in well-being domains for tardive dyskinesia in VMAT2 inhibitor-treated patients via clinician survey and chart review

118 Demographics and Real World Healthcare Cost and Utilization for Patients With Probable Tardive Dyskinesia

Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia

TeleSCOPE: A Real-World Study of Telehealth for the Detection and Treatment of Drug-Induced Movement Disorders

RE-KINECT: A Prospective Study of the Presence and Healthcare Burden of Tardive Dyskinesia in Clinical Practice Settings

Concerns from Community Mental Health Center (CMHC) Patients Regarding Drug-Induced Movement Disorders: Impact on Functioning and Treatment Beliefs

Clinician-Reported Patient Awareness of Symptoms and Severity of Tardive Dyskinesia in Patients Prescribed VMAT2 Inhibitors

The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder

Clinical characteristics and treatment experience of individuals with SCN8A developmental and epileptic encephalopathy (SCN8A-DEE): Findings from an online caregiver survey

Caregiver-Reported Burden in RE-KINECT: Data From a Prospective Real-World Tardive Dyskinesia Screening Study

Cost-effectiveness of opicapone and entacapone in reducing OFF-time in Parkinson's disease patients treated with levodopa/carbidopa

Article Selected to Receive the Mitchell B. Balter Award for 2021

RE-KINECT, A REAL-WORLD, PROSPECTIVE TARDIVE DYSKINESIA SCREENING STUDY: AN EVALUATION OF BASELINE CHARACTERISTICS IN OLDER PATIENTS

PSAT095 Examination of Treatment Patterns in Patients with Classic Congenital Adrenal Hyperplasia (CAH) Compared to Treatment Guidelines

105 Health-Related Quality of Life in Patients with Possible Tardive Dyskinesia Based on Patient and Clinician Assessments

117 RE-KINECT: Real-World Dyskinesia Screening Study and Registry in Patients Taking Antipsychotic Agents: Interim Baseline Burden of Illness Results

PSAT097 Patient Preference Research: Preferred Adjunctive Medication Attributes of Adult Patients with Classic Congenital Adrenal Hyperplasia

6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECT Study

38 Global Improvement and Patient Satisfaction: Results from a Long-term, Open-label, Rollover Study of Valbenazine in Tardive Dyskinesia

MON-183 Adrenal Androgen Control and Steroidal Side Effects in Adolescents and Adults with Congenital Adrenal Hyperplasia Treated with Glucocorticoids

6 Presence and Impact of Possible Tardive Dyskinesia in Patients Prescribed Antipsychotics: Results from the RE-KINECTStudy

Suchergebnisse filtern